|
C1ORF163 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.90179999970397E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.97929999957003E-08 |
| Normal-vs-Stage2 |
1.73192999999294E-05 |
| Normal-vs-Stage3 |
5.924000E-02 |
| Normal-vs-Stage4 |
2.345600E-02 |
| Stage1-vs-Stage2 |
6.559200E-01 |
| Stage1-vs-Stage3 |
2.296400E-02 |
| Stage1-vs-Stage4 |
3.542000E-01 |
| Stage2-vs-Stage3 |
4.279500E-02 |
| Stage2-vs-Stage4 |
2.256000E-01 |
| Stage3-vs-Stage4 |
6.150400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.87139999952413E-07 |
| Normal-vs-AfricanAmerican |
7.10569999951005E-07 |
| Normal-vs-Asian |
5.739000E-01 |
| Caucasian-vs-AfricanAmerican |
3.946200E-01 |
| Caucasian-vs-Asian |
6.502000E-01 |
| AfricanAmerican-vs-Asian |
5.597200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.7486999959182E-08 |
| Normal-vs-Female |
5.439700E-03 |
| Male-vs-Female |
6.380000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.379080E-04 |
| Normal-vs-Extreme_Weight |
9.09200048582193E-10 |
| Normal-vs-Obese |
1.74339999999829E-05 |
| Normal-vs-Extreme_Obese |
1.813600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.646800E-01 |
| Normal_Weight-vs-Obese |
9.093600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.049400E-01 |
| Extreme_Weight-vs-Obese |
1.865760E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.693400E-01 |
| Obese-vs-Extreme_Obese |
6.200200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.728200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.35619999996894E-06 |
| Normal-vs-Age(61-80Yrs) |
1.74089999971372E-07 |
| Normal-vs-Age(81-100Yrs) |
7.52840000000088E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.228000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.135800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.431200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.574000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.558400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.396600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.39064323892535E-12 |
| Normal-VS-Type2 PRCC |
4.144100E-02 |
| Normal-VS-KIRP CIMP |
5.406500E-02 |
| Normal-VS-Unclassified PRCC |
7.68770000000307E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.86527999999075E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.829870E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.160900E-03 |
| Type2 PRCC-VS-KIRP CIMP |
7.519000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.246000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.052400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.80909999999423E-05 |
| Normal-vs-N1 |
3.193000E-01 |
| Normal-vs-N2 |
3.140400E-01 |
| N0-vs-N1 |
1.005720E-02 |
| N0-vs-N2 |
9.306200E-01 |
| N1-vs-N2 |
2.689800E-01 |
|
|
